Indication
Vestibular Vertigo
1 clinical trial
2 products
Clinical trial
Multicenter Randomized Controlled Phase 2 Trial to Evaluate AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery (TRAVERS)Status: Completed, Estimated PCD: 2022-03-28
Product
OralProduct
Intranasal